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We previously described a signaling center, the Frontonasal Ectodermal Zone (FEZ) that regulates growth and patterning of the frontonasal
process (FNP). The FEZ is comprised of FNP ectoderm flanking a boundary between Sonic hedgehog (Shh) and Fibroblast growth factor 8 (Fgf8)
expression domains. Our objective was to examine BMP signaling during formation of the FEZ. We blocked BMP signaling throughout the FNP
prior to FEZ formation by infecting chick embryos at stage 10 (HH10) with a replication-competent avian retrovirus encoding the BMP antagonist
Noggin. We assessed gene expression patterns in the FNP 72 h after infection (∼HH22) and observed that Shh expression was reduced or absent. In
the mesenchyme, we observed that Bmp2 transcripts were absent while the Bmp4 expression domain was expanded proximally. In addition to the
molecular changes, infected embryos also exhibited facial malformations at 72 and 96 h after infection suggesting that the FEZ did not form. Our data
indicate that reduced cell proliferation, but not apoptosis, in the mesenchyme contributed to the phenotype that we observed. Additionally, adding
exogenous SHH into the mesenchyme of RCAS-Noggin-infected embryos did not restore Bmp2 and Bmp4 to a normal pattern of expression. These
data indicate that BMP signaling mediates interactions between tissues in the FNP that regulate FEZ formation; and that the correct pattern of Bmp2
and Bmp4, but not Bmp7, expression in the FNP mesenchyme requires signaling by the BMP pathway.
© 2007 Elsevier Inc. All rights reserved.Keywords: Sonic hedgehog (Shh); Bone morphogenetic proteins (BMPs); FEZ; Craniofacial developmentIntroduction
Formation of the vertebrate face occurs through integrated
development of distinct facial primordia. The upper and lower
jaws are derived from the mandibular, maxillary, and frontonasal
processes (FNP), and the tongue is derived from the hyoid
processes. Our previous research has focused on development of
the frontonasal and maxillary processes (Cordero et al., 2004;
Hu et al., 2003;Marcucio et al., 2005).Within the FNP two types
of mesenchymal cells are present. The neural crest cells will give
rise to the connective tissues, and the mesoderm will give rise to
the endothelium of the vascular network (Couly and Douarin,
1988; Evans and Noden, 2006). These mesenchymal cells are⁎ Corresponding author. Fax: +1 415 206 8244.
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ectoderm, and development of the middle and upper face is
regulated by a series of signaling interactions among the fore-
brain, the mesenchyme, and the facial ectoderm (Eberhart et al.,
2006; Gunhaga et al., 2000; Hu et al., 2003; Marcucio et al.,
2005; Martinez-Barbera et al., 2001; Niederreither et al., 1999;
Schneider et al., 2001; Shigetani et al., 2000; Wada et al., 2005;
Ye et al., 1998).
The ectoderm of the FNP regulates development of the upper
beak of birds (Hu et al., 2003). Sonic hedgehog (Shh) and Fi-
broblast Growth Factor-8 (Fgf8)-expressing cells form a
boundary in the ectoderm of the FNP that corresponds to the
distal tip of the upper beak (Hu et al., 2003). Transplantation of
the ectoderm flanking this boundary induced the formation of
ectopic upper beak structures that reflected the dorsoventral
polarity of the grafted tissue (Hu et al., 2003). Furthermore,
inhibiting formation of this boundary led to truncations of the
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Collectively, these data suggest that this signaling center,
which we named the Frontonasal Ectodermal Zone (FEZ),
coordinates patterned outgrowth of the FNP.
The specific role of FGF8 and SHH in mediating FEZ
function is not known. FGF8 is required for initial FEZ activity
(Hu et al., 2003), but data indicate that Fgf8 needs to be down-
regulated for normal development of the FNP (MacDonald et al.,
2004). In contrast Shh expression in the FEZ appears to be
required for FNP outgrowth (Cordero et al., 2004; Marcucio et
al., 2005) and ectopic SHH promotes expansion of the FNP (Hu
and Helms, 1999). Finally, signaling by the combination of
FGF8 and SHH induced ectopic cartilage outgrowths in the head
of chick embryos (Abzhanov et al., 2004). These results suggest
that SHH signaling may be essential for the FEZ to function.
However, mechanisms that regulate formation of this signaling
center and the identities of the molecular mediators and targets of
FEZ activity are unknown.
Bone morphogenetic proteins (BMPs) are important for
development of the face. There is clear evidence that signaling
by BMPs is essential for development of the axial and appen-
dicular skeleton (reviewed in Yoon and Lyons, 2004). However,
BMP signaling also regulates many aspects of morphogenesis.
Variations in BMP signaling created morphological diversifica-
tion that reflected species-specific form of the middle and upper
face (Abzhanov et al., 2004; Wu et al., 2004). Furthermore,
modulating BMP signaling within the maxillary process exerted
a profound influence on morphology of the maxillary deriva-
tives; blocking BMP signaling while stimulating the retinoid
pathway led to a conversion of the maxillary process to a struc-
ture that resembled a duplicated FNP (Lee et al., 2001). The
importance of BMP signaling to FNP development (Abzhanov
et al., 2004; Wu et al., 2004), regulation of Bmp2 expression by
SHH signaling (Hu and Helms, 1999), and the expression
patterns of Bmps within the FNP (Francis-West et al., 1994) has
led us to initiate a series of experiments designed to examine the
effects of BMP signaling within the FNP. We blocked BMP
signaling in the FNP of avian embryos prior to the arrival of
neural crest cells and then examined the resulting molecular and
morphological alterations.
Results
The FEZ is a putative target of BMP signaling
Our initial step in assessing the role of BMP signaling during
development of the FNP was to determine the cellular targets of
BMP signaling prior to and immediately after FEZ formation. As
neural crest cells migrate into the FNP, Shh expression is in-
duced within the stomodeal ectoderm (Marcucio et al., 2005).
Prior to the onset of Shh expression at HH20 (Cordero et al.,
2004; Marcucio et al., 2005), BMP receptor Type R1b (BmpR1b)
is expressed in the facial ectoderm (HH15; Fig. 1A) and
mesenchyme (HH17; Fig. 1B) within the FNP. Similarly BMP
receptor Type R1a (BmpR1a) is expressed throughout the FNP
(HH15 and HH17; Figs. 1D, E, respectively). At HH22, after
outgrowth of the FNP has begun, expression of BmpR1b andBmpR1a exhibits widespread expression in the facial mesench-
yme and the brain ectoderm (Figs. 1C, F). These data suggest
that ectodermal cells comprising the FEZ are targets of BMP
signaling prior to FEZ formation and indicate that the targets of
BMP signaling may change rapidly during the early stages of
development of the FNP.
Blocking BMP signaling prevents formation of the FEZ
Since tissue comprising the FEZ is a likely target of BMP
signaling, our next objective was to examine the effect of
blocking BMP signaling on development of the FNP. We
infected the neural crest cells migrating to the frontonasal
process with a replication-competent retrovirus encoding the
BMP antagonist Noggin (RCAS-Noggin) by injecting the virus
into the mesenchyme adjacent to the forebrain of HH10 embryos
(Fig. S1). Embryos were infected at this time, because the neural
tube has closed, and neural crest cells have emigrated from the
forebrain and midbrain (Tosney, 1982) and were moving into the
FNP. Thus, generation of neural crest cells was not altered by our
treatment.
Fgf8 and Shh are key components of the FEZ (Abzhanov and
Tabin, 2004; Hu et al., 2003). Therefore, our first objective was
to identify changes in the pattern of expression of these genes
before (48 h after infection, ∼HH18) and after (72 h after
infection, ∼HH22) FEZ formation in embryos infected with
RCAS-Noggin. Blocking BMP signaling did not alter the down-
regulation of Fgf8 expression in most of the embryos (n=7/10;
data not shown). At HH22, Fgf8 is normally down-regulated in
the midline of the FNP but a few embryos (n=3/10) exhibited a
small area of Fgf8-expressing cells located in the ectoderm
below the optic recess (Fig. 2E). We found that Shh expression
was altered by RCAS-Noggin treatment (n=13/14). In embryos
examined 72 h after infection with RCAS-Noggin (∼HH22),
Shh transcripts were either absent (n=5/14; not shown) or the
Shh expression domain was greatly reduced (n=8/14; Fig. 2F;
see also Fig. 7C) in the facial ectoderm compared to normal (Fig.
2B) and control embryos (Fig. 2D). Shh expression in the
diencephalon and telencephalon was not altered in embryos
infected with RCAS-Noggin. To ensure that the ectoderm
destined to express Shh did not undergo apoptosis, we performed
a TUNEL analysis at 48 h (∼HH18; n=4 RCAS-Noggin, n=4
RCAS-AP) and 72 h (∼HH22; n=3 RCAS-Noggin, n=2
RCAS-AP) after infection with RCAS-Noggin. We observed no
evidence of DNA fragmentation in any of the cells in the
ectoderm of embryos infected with RCAS-Noggin (data not
shown). To distinguish the effect of Noggin mis-expression in
the FNP mesenchyme versus the stomodeal ectoderm, we
infected the ectoderm in embryos beginning at HH14, because at
this time the ectoderm covering the face is easily targeted. We
observed no alteration of the phenotype at HH22 (n=4; data not
shown). Together, these observations indicate that Noggin ex-
pression in the facial mesenchyme does not affect the timing of
down-regulation of Fgf8 expression, but perturbs the induction
sequence of Shh in the stomodeal ectoderm of the face. Thus,
formation of the FEZ is disrupted when BMP signaling within
the mesenchyme is blocked by Noggin.
Fig. 1. Bone morphogenetic proteins receptors are expressed in stomodeal ectoderm of avian embryos prior to FEZ formation. (A) Bone morphogenetic protein receptor 1b (BmpR1b) (red) is expressed in the brain and
facial ectoderm of HH15 embryos, and (B) at HH17 is also expressed in the mesenchyme. (C) At HH22, this BmpR1b is expressed throughout the brain and facial mesenchyme. (D) Bone morphogenetic protein receptor
1a (BmpR1a) (green) transcripts are detected in the ectoderm and mesenchyme of the face and mandible, and in the brain at HH15 and (E) at HH17. (F) At HH22, BmpR1a exhibits widespread expression in the face and
brain. Yellow arrowheads indicate expression in the ectoderm. Scale bar: A, B, D, E=100 μm; C, F=500 μm.
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Fig. 2. Blocking BMP signaling alters Shh expression in facial ectoderm. (A) At HH22 Fgf8 transcripts (yellow) are normally detected in the telencephalon, the optic
recess, and endoderm of the mandible. In the ectoderm spanning, the midline of the FNP, Fgf8 has been down-regulated by this time. (B) Shh transcripts (red) are
present in the diencephalon and telencephalon as well as in the facial ectoderm in untreated embryos at HH22. (C) Patterns of Fgf8 and (D) Shh expression are not
altered in RCAS-AP-infected controls. (E) In embryos infected with RCAS-Noggin, Fgf8 transcripts exhibited normal pattern of expression (n=7/10). In rare cases
(n=3/10), a few cells expressing Fgf8 were detected in the ectoderm below the optic recess (yellow arrowhead). (F) In the brain of embryos infected with RCAS-
Noggin, Shh expression at HH22 is normal. However, in the facial ectoderm, the Shh expression domain was either reduced (n=8/14) or Shh transcripts were absent
(n=5/14). te, telencephalon; or, optic recess; di, diencephalon; fe, facial ectoderm; ma, mandible; Scale bar: 500 μm.
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We used multiple approaches to examine the extent to which
BMP signaling was inhibited by the expression of Noggin. First
we analyzed the expression of Msx1 and Msx2, which are
known to be activated by the BMP signaling pathway (Barlow
and Francis-West, 1997) among others (Hussein et al., 2003; Tan
et al., 2002). No difference in Msx1 and Msx2 expression was
observed between treated and control embryos (Fig. S2). To
ensure that the BMP pathway was blocked, we used an in vivo
functional assay that is based on the necessity of BMP signaling
for skeletal formation (reviewed in Yoon and Lyons, 2004; Wan
and Cao, 2005). Since infecting embryos at HH10 leads to death
between HH26 and HH30, which is prior to skeletal develop-
ment, we infected the right mandibular primoridium of embryos
at HH22 with the RCAS-Noggin virions. At 13 days of
incubation, we observed an absence of bone and cartilage on
the treated compared to the control side. Specifically, the mandi-bular cartilage and the adjacent bones weremissing (Fig. 3). This
result indicates that RCAS-Noggin infection was able to inhibit
the BMP signaling pathway to a degree that completely
abrogated skeletal development.
Malformations in embryos infected with RCAS-Noggin suggest
FEZ inactivity
Our gene expression data indicate that the FEZ does not form
properly when BMP signaling is blocked. A gross morpholo-
gical analysis of RCAS-Noggin-infected embryos (RCAS-
Noggin, n=55; RCAS-AP, n=30; Normal, n=45) revealed
that blocking BMP signaling prior to FEZ formation created
severe FNP malformations (Fig. 4G). The progression of the
phenotype was directly related to the extent of retroviral
infection. At 24 h post-infection (∼HH14), no obvious mal-
formations were evident (RCAS-Noggin, n=6; RCAS-AP,
n=4; Normal, n=4), and neural crest cells had not arrived in
Fig. 3. RCAS-Noggin blocks the functionality of the BMP signaling pathway. Safranin O/Fast Green staining of a coronal section of day 13 chick embryo (∼HH39)
infected at∼HH22 in the right mandibular primordium illustrates the absence of bone and cartilage (∗) on this side. The lower jaw skeleton is outlined on the other side
of the face. mc, mandibular cartilage; sa, sarangular bone; sp, splenial bone; dt, dentary bone. Scale bar: 1 mm.
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n=10; RCAS-AP, n=7; Normal, n=8), embryos infected with
RCAS-Noggin exhibited altered development of the maxillary
and mandibular processes, but the FNP appeared unaltered
(Fig. S3). At this time, the maxillary and mandibular processes
were small and FNP outgrowth had not begun. In these embryos,
widespread expression of vENV (Fig. S3) and Noggin (Fig. S3)
was evident throughout the head. By 72 h (∼HH22; RCAS-
Noggin, n=25; RCAS-AP, n=14; Normal, n=22) and 96 h
(∼HH26; RCAS-Noggin, n=14; RCAS-AP, n=5; Normal,
n=11), the malformations were very severe, and retroviral
infection was widespread (Fig. 4). The maxillary processes were
rudimentary, the eyes were rotated forward, the FNP exhibited
no signs of proximodistal extension, and the nasal pits were
small. At 72 h (∼HH22), the facial mesenchyme of RCAS-
Noggin treated embryos was abundant and was comprised of a
large number of cells (e.g., Figs. 4H, Q). Other embryos were
allowed to develop to later stages in order to examine the impact
of NOGGIN on formation of the skeletal elements of the upper
beak. The malformations were severe at 96 h post-infection
(∼HH26; Figs. 4J–R). Unfortunately, we were unable to
analyze later developmental events in infected embryos, because
most embryos died between 96 and 120 h post-infection. Only 2
embryos survived for 6 days after infection (8 days total
development), and an analysis of the skeleton of the face could
not be performed.
We next sought to determine whether changes in cell pro-
liferation within the FNP could have contributed to the pheno-
type that we observed. We analyzed BrdU incorporation 48 h
(∼HH18) and 72 h (∼HH22) after infection with RCAS-Nog-
gin. We observed no significant difference in the proportion of
proliferating cells within the facial mesenchyme at 48 h after
infection (∼HH18; ANOVA, pN0.05, groups: Normal (n=5)
average=27%, SD=17%; RCAS-AP (n=5) average=31%,
SD=7.5%; RCAS-Noggin (n=5) average=25%, SD=11%).
However, we found a statistically significant reduction in the
proportion of proliferating cells within the facial mesenchyme at
72 h after infection with RCAS-Noggin (∼HH22; ANOVA,
pb0.05, groups: Normal (n=3) average=23.6%, SD=12.3%;
RCAS-AP (n=4) average=25%, SD=5.8%; RCAS-Noggin
(n=3) average=6.1%, SD=3.9%). At this time, we did not
detect significant changes in cell proliferation in the stomodealectoderm (ANOVA, pN0.05, groups: Normal (n=3) aver-
age = 5.2%, SD=5.7%; RCAS-AP (n= 4) average = 8%,
SD=1.8%; RCAS-Noggin (n=3) average=4.2%, SD=3.4%).
We next analyzed the BrdU incorporation qualitatively at 96 h
after infection (∼HH26; Fig. 5). Normally at this time a focal
zone of proximodistal extension is evident in the FNP (Figs.
4K, N). However, in embryos infected with RCAS-Noggin,
there was no evidence of this focal zone of growth (Fig. 4). We
observed an actively proliferating zone of growth in RCAS-AP
control embryos (Figs. 5C, D) which was absent in RCAS-
Noggin treated embryos (Figs. 5A, B). We observed very few
apoptotic cells in treated and control embryos at ∼HH18 or
∼HH22, and we found no evidence that RCAS-Noggin
infection increased cell death (data not shown). Likewise, at
∼HH26 we observed no apoptosis within the region depicted in
Fig. 5 (data not shown). Thus, blockade of BMP signaling
inhibited the formation of the growth zone within the FNP by
decreasing cell proliferation, but did not increase cell death.
Over-expression of Noggin in the FNP alters Bmp2 and Bmp4
expression patterns
Our previous data indicated that the FEZ directs gene ex-
pression in the underlying mesenchyme (e.g., Hu et al., 2003). In
this investigation, we compared the expression patterns of
Bmp2, Bmp4, and Bmp7 at 72 h (∼HH22) among embryos
infected with RCAS-Noggin, RCAS-AP, and normal embryos,
because these molecules are expressed within the mesenchyme
and are important for development of the FNP (Abzhanov et al.,
2004). Bmp7 expression was unaffected by RCAS-Noggin
treatment (Fig. 6H, n=6/6) compared to untreated (Fig. 6B,
n=3/3), and control embryos (Fig. 6E, n=7/7). However, we
observed perturbations of the Bmp2 and Bmp4 expression
domains. In normal embryos (Fig. 6A, n=5/5) and RACS-AP-
infected embryos (Fig. 6D, n=7/7) Bmp2 was expressed in
mesenchyme adjacent to the diencephalon and in the epithelium
of Rathke's pouch. In embryos infected with RCAS-Noggin
(Fig. 6G, n=8/8), Bmp2 transcripts were restricted to the
proximal portion of Rathke's pouch, and Bmp2 was not
expressed in the surrounding mesenchyme. Bmp4 transcripts
are normally detected in the distal mesenchyme of the FNP at
HH22 (Figs. 6C, n=4/4 and 7F, n=7/7). In embryos infected
108 S. Foppiano et al. / Developmental Biology 312 (2007) 103–114with RCAS-Noggin, the Bmp4 expression domain was
expanded proximally and extended beneath the optic recess
(Fig. 6I, n=10/10). These perturbations in expression of Bmp2
and Bmp4 may be a direct consequence of blocking BMPsignaling or could have resulted from disrupted signaling from
the FEZ that formed in these embryos.
In our last experiment, we wanted to determine the effect of
restoring SHH to the FNP on Bmp2 and Bmp4 expression. We
Fig. 5. Cell proliferation. (A) Low magnification of BrdU immunostaining of a sagittal section at 96 h (∼HH26) post-RCAS-Noggin infection. BrdU positive cells are
present in the brain (red arrowhead). (B) Higher magnification of area corresponding to the box in A illustrates the absence of proliferative cells in this region. (C) Low
magnification of BrdU immunostaining of sagittal section of control embryo at 96 h (∼HH26) after infection. BrdU-positive cells are present in the brain (red
arrowhead), and (D) a higher magnification of the area corresponding to the box in panel C illustrates the presence of a large number of proliferative cells in this
location (red arrowhead). Scale bars: 100 μm.
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then 48 h later at ∼HH18, we restored SHH in the mesenchyme
by implanting a bead soaked in the amino terminal portion of
SHH protein (SHH-N; (Fig. 7A). Twenty-four hours after bead
implantation (∼HH22), we examined gene expression in the
FNP. SHH signaling was evident by the widespread expression
of the down-stream target, Patched (Ptc; Fig. 7B, n=10/10),
even though the endogenous domain of Shh was reduced (Fig.
7C, n=10/10). In these embryos (Fig. 7F), placement of SHH-
N in the FNP was not able to restore the normal expression of
Bmp4 and Bmp2 in the mesenchyme (Figs. 7D and E,
respectively, n=10/10).
Discussion
Blocking BMP signaling leads to facial malformations and
alters gene expression
Our goal was to determine whether BMP signaling is required
for FEZ formation and FNP outgrowth. To achieve this we
blocked BMP signaling by injecting a replication-competentFig. 4. Blocking BMP signaling causes severe facial malformations. (A) Morpholog
detected in untreated embryos. (D) Morphology of HH22 embryos infected with RCA
the face of infected embryos. (F) Noggin transcripts were not detected. (G) RCAS-N
maxillary processes, forward rotation of the eyes, apparent lack of proximodistal expa
Noggin transcripts (purple). (J) Normal appearance of embryos at HH26 illustrates th
vENV and (L) Noggin were not expressed. (M) RCAS-AP embryos appeared norm
extension is indicated by the red arrowhead. (O) Noggin transcripts were not detected
facial malformations at HH26. (Q) vENV transcripts were detected in a wide area ove
was not observed in treated embryos. Scale bars: A, J=1 mm; B=500 μm.avian retrovirus encodingNoggin into the mesenchyme adjacent
to the forebrain of HH10 chick embryos. At this developmental
stage, emigration of neural crest cells from the neural tube is
complete. Propagation of the virus within the embryo led to
widespread infection of the FNP crest within 48 h (∼HH18).
However, this also led to infection of more caudal populations of
neural crest cells as well as the paraxial mesoderm populations of
the head. Thus, the mandibular arch and mesodermal derivatives
were infected by RCAS-Noggin.
Embryos infected with RCAS-Noggin had severe facial
malformations. At HH22 and 26, we observed a phenotype
characterized by lack of proximodistal extension of the FNP,
rudimentary maxillary processes, small nasal pits, and forward
rotation of the eyes. The phenotype that we observed was caused
by reduced cell proliferation in the facial mesenchyme. These
data indicate that BMP signaling does not regulate expansion of
the ectoderm, but BMP signals regulate growth within the
mesenchyme of the FNP. Furthermore, these changes indicate
that the normal zone of proximo-distal extension within the FNP
is regulated by BMP signaling. Our data agree with previously
published reports illustrating the importance of BMP signalingy of untreated embryos at HH22. (B) vENV and (C) Noggin transcripts were not
S-AP appeared normal. (E) vENV transcripts (orange) were detected throughout
oggin treated embryos exhibit a severe phenotype characterized by rudimentary
nsion of the FNP, and small nasal pits. (H) vENVexpression overlapped with (I)
e growth zone (red arrow) located at the tip of the FNP. (K) In normal embryos,
al, (N) vENV transcripts were widely expressed, and the site of proximodistal
in control embryos. (P) Embryos infected with RCAS-Noggin exhibited severe
rlapping with (R) Noggin expression. The focal zone of proximodistal extension
Fig. 6. Bmp expression is perturbed in RCAS-Noggin-infected embryos. (A) Bmp2 transcripts (green) were detected in the mesenchyme adjacent to the diencephalon
and in the epithelium of Rathke's pouch in untreated embryos at HH22 (n=5). (B) Bmp7 transcripts (yellow) were observed in the dorsal mesenchyme (n=3). (C)
Bmp4 (purple) was normally expressed in the distal mesenchyme (n=4). (D) Bmp2, (E) Bmp7, (F) and Bmp4 expression appeared unaltered in RCAS-AP controls
(n=7). (G) In embryos infected with RCAS-Noggin, Bmp2 was expressed in the epithelium of Rathke's pouch but is not detected in the surrounding mesenchyme
(n=8). (H) Bmp7 expression was unaltered by RCAS-Noggin infection (n=6). (I) The Bmp4 expression domain was extended proximally beneath the optic recess in
RCAS-Noggin-infected embryos (n=10). te, telencephalon; or, optic recess; di, diencephalon; ma, mandible; rp, Rathke's pouch. Scale bar: 500 μm.
Fig. 7. Can Shh restore Bmp expression patterns? (A)Morphology of∼HH22 embryos after infection with RCAS-Noggin and implantation of a bead soaked in SHH-N
(blue bead). The phenotype changes already described are present in these embryos (n=10/10). (B) Ptc transcripts are present in the mesenchyme surrounding the bead
indicating that the exogenous SHH-N is bioactive (n=10/10). (C) The Shh expression domain in the ectoderm is reduced (n=10/10). (D) The Bmp4 expression domain
was extended proximally beneath the optic recess (n=10/10), and (E) the Bmp2 expression domain is restricted to the epithelium of Rathke's pouch. Bmp2 expression
was not restored to the mesenchyme (n=10/10). (F) Noggin transcripts are detected throughout the FNP. rp, Rathke's pouch. Scale bars: A=1 mm; B–F=500 μm.
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2005; Wu et al., 2006; Wu et al., 2004). In addition to the
alterations in cell proliferation in the mesenchyme, we also
observed molecular changes in the FEZ and mesenchyme that
likely contributed to the phenotype. Specifically, Shh expression
was down-regulated in the FEZ, Bmp2 was down-regulated in
the facial mesenchyme, and concomitantly the Bmp4 expression
domain was expanded proximally. Lastly, our data demonstrate
that when exogenous SHH protein was provided to the FNP
mesenchyme, the normal patterns of BMP expression were not
restored.
BMP signaling is required for development of a functional FEZ
Epithelial–mesenchymal interactions that regulate develop-
ment of the upper jaw are controlled, in part, by the FEZ (Hu et
al., 2003). Our current data clearly demonstrate that BMP
signaling regulates Shh expression in the FEZ. However, the
mechanism underlying this regulation is not known. For
instance, BMP signaling could directly activate transcription
of the Shh locus in the FEZ. Alternatively, Shh expression could
be regulated by a signaling molecule that is down stream of
BMPs. We have already shown that SHH signaling within the
forebrain is required for the onset of Shh expression within the
FEZ, and that SHH does not appear to act directly on the FEZ to
regulate Shh expression (Marcucio et al., 2005). Instead, an
undefined, SHH-dependent, signal from the brain is required.
Collectively, these previous and our current data suggest that
part of this signaling network includes BMPs. We are currently
assessing the ability of various signaling pathways to restore Shh
expression within these various embryos.
Could Shh expression be regulated by members of the TGF-β
superfamily?
Control of Shh expression occurs via multiple mechanisms in
both a tissue- and a time-specific manner through a complex
series of transcriptional activators and repressors (e.g., Epstein et
al., 1999). However, to date no regulatory elements have been
identified in or around the Shh locus that potentially regulate
expression of Shh within the FEZ. In the limb bud, BMP
signaling indirectly suppresses Shh expression in the Zone of
Polarizing Activity by disrupting the positive feedback loop
between FGF and SHH signaling (Pizette andNiswander, 1999).
In fact, normally the activity of the BMP antagonist Gremlin is
required to suppress BMP signaling and maintain function of the
Apical Ectodermal Ridge (Khokha et al., 2003). Similarly, in the
anterior portion of the head, increased BMP signaling correlates
with reduced Shh expression (Anderson et al., 2002; Ohkubo et
al., 2002), and a balance of signaling among BMPs, SHH, and
FGF8 is necessary for correct patterning and development of the
forebrain (Ohkubo et al., 2002). From these data, we would have
predicted that blockade of BMP signaling in the FNP would
have led to an increase of Shh expression as observed in the limb
(Zuniga et al., 1999).
Our current data demonstrate an opposite effect; BMP
signaling appears to be required for Shh expression in theFEZ. There is no evidence that BMP signaling activates
transcription of the Shh locus directly, but there is a precedent
that the Shh locus can be activated by Smad signaling. Cyclops
(Cyc), a member of the TGFβ superfamily of molecules, directly
regulates Shh expression within the floor plate of the neural tube
of zebrafish embryos (Muller et al., 2000). Furthermore, sig-
naling by BMP4 regulates expression of Shh expression in the
dental (Chen et al., 1996) and the palatal (Zhang et al., 2002)
epithelium in mice. In the mandible of chicken embryos,
extension of the Shh expression domain within the ectodermwas
observed after application of ectopic BMP proteins. This ex-
tension occurred in conjunction with an expansion of Msx ex-
pression domains. In these experiments,Msx genes were shown
to be directly up-regulated by BMP signaling (Barlow and
Francis-West, 1997). However, in our experiments, we did not
detect any noticeable changes in the expression patterns ofMsx1
and Msx2, and this has been observed by others (Ashique et al.,
2002). In fact, activity of MSX1 appears to be, in part, upstream
of Bmp4 expression in the mesenchyme of the developing
mouse face, because transgenic expression of Bmp4 in the
Msx1−/−mouse is able to rescue the clefting defect (Zhang et al.,
2002). In addition, Msx2 expression is regulated in a BMP-
independent manner through the activity of the transcription
factor YY1 (Tan et al., 2002) which is expressed in the ectoderm
covering the FNP (data not shown). Lastly, data indicate that
signaling via the canonical Wnt pathway is also able to regulate
expression of Msx genes (Hussein et al., 2003). Thus, while
MSX activity may mediate some components of BMP signaling,
in the developing face the epithelial–mesenchymal interactions
appear to be mediated by a genetic signaling network among
various molecular pathways. BMPs, SHH, and MSX gene-
products may act to integrate these signaling networks.
Improper FEZ formation may result in changes in Bmp2 and
Bmp4 expression
Our data demonstrate that BMP signaling is required for
development of a functional FEZ. Embryos infected with
RCAS-Noggin exhibited severe craniofacial malformations
that are reminiscent of the absence of a functional FEZ (Cordero
et al., 2004; Marcucio et al., 2005). In addition to morphological
changes, we observed changes in gene expression patterns in the
FNP mesenchyme. The Bmp4 expression domain was extended
proximally, and Bmp2 expression was restricted to the ectoderm
adjacent to Rathke's pouch and absent from the surrounding
mesenchyme. These changes could have resulted from either the
blockade of BMP signaling or the reduced Shh expression in the
FEZ or both. The ability of SHH signaling to govern expression
of Bmp2 and/or Bmp4 had been demonstrated in the vertebrate
limb bud (Laufer et al., 1994), the hindgut (Roberts et al., 1995),
and in the face (Hu and Helms, 1999; Zhang et al., 2002).
Specifically, in the FNP of developing chick embryos, beads
soaked in SHH-N induced Bmp2 expression in adjacent
mesenchymal cells (Hu and Helms, 1999). However, in our
experiments, exogenous SHH protein in the mesenchyme was
not able to restore the normal pattern of Bmp2 expression in
presence of exogenous Noggin. Together these data seem to
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mesenchyme in a BMP-dependent fashion.
Disruptions to BMP signaling create craniofacial
malformations
Craniofacial malformations can occur as a result of disrupting
BMP signaling. Mutations in the BMP antagonist Noggin result
in facioaudiosymphalangism syndrome, which, among other
skeletal defects, is characterized by broad hemicylindrical nose,
and hypoplasia of alae nasi, long face, and ontological
abnormalities (Declau et al., 2005; Obregon et al., 2000).
Morphologically, these changes agree with the results of our
study that suggest increased BMP signaling would increase
growth of the FNP. Another member of the BMP signaling
pathway has also been implicated in human disease. Mutations
in the SOST gene, which encodes sclerostin, a BMP antagonist
and negative regulator of bone formation, result in sclerosteosis
or Van Buchem disease (van Bezooijen et al., 2005). These
closely related disorders are characterized by progressive bone
thickening resulting in craniotubular sclerosing dysplasia with
associated facial and skeletal malformations (Balemans et al.,
1999; Nager and Hamersma, 1986).
While specific craniofacial malformations have been shown
to result from mutations in BMP antagonists, our experiments
reveal that interactions between SHH and BMP signaling
pathways may be susceptible to teratogens. Craniofacial
malformations are common and create substantial psychologi-
cal burden on patients and their families. These birth defects
arise as a result of genetic or environmental perturbations that
disrupt developmental processes. For instance, genetic altera-
tions or teratogens that disrupt cell and tissue interactions can
have catastrophic effects. Mutations in the gene encoding So-
nic hedgehog (Belloni et al., 1996; Roessler et al., 1996) or
disruptions in SHH signaling by teratogens such as cyclopa-
mine (Cordero et al., 2004; Coventry et al., 1998; Incardona et
al., 1998; Keeler, 1973; Keeler, 1975; Keeler, 1978), alcohol,
or retinoids (Cohen and Shiota, 2002) can lead to holopro-
sencephaly (HPE). This condition is characterized by a
spectrum of defects in forebrain and facial development
(Roessler and Muenke, 1998). The extreme form of HPE
manifests as cyclopia (Cohen et al., 1971; Muenke and Beachy,
2000) and results from early disruption of Shh expression in
the brain and face (Anderson et al., 2002; Cordero et al., 2004).
Microforms of HPE result in a single, central incisor,
narrowing of the space between the eyes, and/or median cleft
lip and palate (Muenke et al., 1994), and these defects can arise
from disruption to SHH signaling within the face itself
(Cordero et al., 2004). In addition to genetic mutations or
molecules that disrupt the ability of SHH to bind to its receptor,
mutations or molecules that disrupt the Shh induction sequence
could also elicit defects of the brain and/or the face. For
example, we have demonstrated that disruption of the Shh
induction sequence at discrete times within the head creates the
spectrum of defects that are associated with HPE (Cordero
et al., 2004). The data presented here suggest that BMP
signaling regulates formation of the FEZ, and that members ofthe BMP pathway could be targets for teratogens that cause
formes frustes of HPE.
Experimental procedures
Preparation of Noggin expressing avian virus (RCAS-Noggin)
Replication-competent avian sarcoma retroviral vector encoding chicken
Noggin cDNA, alkaline phosphatase, or Shh (RCAS-Noggin, RCAS-AP or
RCAS-Shh respectively) were produced as described (Fekete and Cepko, 1993).
Briefly, virus stocks were prepared by transfection of proviral DNA plasmid into
immortalized chicken embryonic fibroblasts (DF-1 cells). Transfected DF-1 cells
were expanded in Dulbecco's Minimum Essential Medium (DMEM) supple-
mented with 10% fetal bovine serum (FBS). After 2 passages, cells were grown
under low serum conditions (1% FBS) and virions were harvested over 3
consecutive days from confluent cultures. Viral supernatants were concentrated
by centrifugation at 25,000 rpm for 3 h at 4 °C. After discarding the supernatants,
viral pellets were re-suspended in low serum culture medium, and 10 μl aliquots
were frozen at −80 °C.
Infection with RCAS-Noggin virus
Virus-dye solutions (10 μL of virus supplemented with 1 μl of 0.02% Fast
Green) were prepared at the time of injection to allow visualization of injected
solutions. A pulled borosilicate glass capillary pipette (OD=1.0 mm;
ID=0.5 mm; Sutter Instrument, Novato, CA) connected to a KITE-R
micromanipulator (World Precision Instruments Sarasota, FL) was loaded with
the virus-dye solution. Embryos (SPAFAS) were incubated to HH10, HH14, or to
HH22 and then a hole wasmade in the shell. A solution of neutral red was applied
to the vitelline membrane to visualize the embryo. Injections were carried out
using a PV830 Pneumatic Picopump (World Precision Instruments Sarasota, FL).
Approximately 100–150 nl of virus-dye solution was injected into the
mesenchyme on each side of the forebrain (see Fig. S1 for site of injection) of
HH10 embryos. Viable embryos were euthanized and collected at 24, 48, 72, and
96 h post treatment. The stomodeal ectoderm of HH14 embryos was infected
with RCAS-Noggin by injecting approximately 100–150 nl of virus-dye solution
into the mouth. Embryos were euthanized and collected 48 h post treatment
(∼HH22). RCAS-Alkaline phosphatase (RCAS-AP) virus, similarly prepared,
and was used to infect control embryos. To assess the ability of RCAS-Noggin to
block skeletogenesis in the jaw, embryos were incubated to HH22 and the right
side of the mandible was injected with RCAS-Noggin virions. Embryos were
euthanized after 13 days of incubation.
SHH-N beads
Affi-gel blue beads (50–100 mesh, 200–250 μm diameter; Biorad) were
soaked in recombinant SHH-N protein (800 μg/ml in PBS 0.1% bovine serum
albumin (BSA) Ontogeny) for 1 h at 37 °C; beads were implanted into the FNP of
∼HH18 embryos (Marcucio et al., 2005). Embryos were collected after an
additional 24 h of incubation (∼HH22), and prepared for analysis of gene
expression.
Embryo processing
Embryoswere fixed in 4%paraformaldehyde at 4 °C overnight, transferred to
PBS containing 0.01% ethidium bromide, and photographed using a Leica
MFLZIII dissecting microscope equipped with epifluorescent illumination.
Embryos were then dehydrated and embedded in paraffin. Sections, 7 μm
sagittal, were then prepared.
In situ hybridization
In situ hybridization was performed on paraffin wax embedded sections as
previously described (Albrecht et al., 1997). Subclones of v-ENV, Noggin, Shh,
Fgf8, Bmp2, Bmp4, Bmp7, Msx1, Msx2, and Patched (Ptc) were linearized for
transcription of 35S-labeled antisense riboprobes.
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Sections from day 13 embryos were stained with safranin O/Fast green (SO/
FG) to visualize cartilage (red) (Lu et al., 2006).
BrdU labeling
Embryos were infected with RCAS-Noggin as described. Forty-eight, 72, or
96 h after infection and 20min prior to collection, 200 nl of BrdU labeling reagent
(Zymed, South San Francisco, CA) was injected into a blood vessel near the
heart. Embryos were fixed, embedded, and sectioned as described. BrdU-labeled
cells were visualized on paraffin sections; detection of BrdU incorporation was
assessed by immunohistochemistry and detection with diaminobenzidine (DAB)
followed by counterstaining all nuclei with hematoxylin following the
manufacturer's instructions (Zymed). At 48 h after infection, the percentage of
proliferating cells in medial and lateral sections was determined on images
captured using Adobe Photoshop. At 72 h after infection, the percentage of
proliferating cells in medial sections was similarly determined. Analysis of
Variance (ANOVA) was performed on medial or lateral sections separately to
determine statistical significance.
TUNEL analysis
DNA fragmentation was examined using a TUNEL kit following the
manufacturer's instructions (Apoptag Plus, Intergen).Acknowledgments
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